Pilot R & D and Production Platform
Having the ability of development of small scale processes and pilot production. The expression of Fed-Batch culture reaches the international leading level.
Having drug discovery platforms of affinity chromatography, ion exchange chromatography, composite mode chromatography, nano filtration and other purification chromatography technologies. Having... morePilot R&D and Production https://www.sungenbiomed.com/pilot-r-d-and-production-platform/
Pilot R & D and Production Platform
Having the ability of development of small scale processes and pilot production. The expression of Fed-Batch culture reaches the international leading level.
Having drug discovery platforms of affinity chromatography, ion exchange chromatography, composite mode chromatography, nano filtration and other purification chromatography technologies. Having capacity of fine purification of target antibodies and production of high purity protein stock solution.
Having a mature preparation filling platform, which produces different specifications of drug products such as pre-filled syringes, vials, and cilin bottles, and the filling accuracy exceeds the industry average level.
Last posted by Doslkn on March 14 2024 at 02:35 PM
Employee drug testing is subject to various regulations and guidelines designed to ensure fairness, accuracy, and compliance with legal requirements. Employers must understand these regulations...
COVID-19 Impact Analysis on Drug-eluting Balloon Catheters Market report published by Value Market Research provides a detailed market analysis comprising market size, share, value, growth and tren...
Imagine tiny bubbles, smaller than a red blood cell, carrying powerful medicines directly to diseased cells. This isn't science fiction, it's the cutting edge of drug delivery with drug-loaded ...
Market Scenario
The global drug infusion system market size is presumed to demonstrate a healthy growth rate during the appraisal period (2023-2030) owing to the adoption of technologically adva...
Posted by amol on January 16 2024 at 06:27 AM
public
The globalAtopic Dermatitis drugs marketsize reached USD 8.15 Billion in 2022, with expectations to reach USD 12.11 Billion by 2032, marking a revenue Compound Annual Growth Rate (CAGR) of 4.5% d...
Theglobal AI in drug discovery marketis estimated to grow significantly, at a CAGR of 51.3%, during the forecast period. In recent years, the demand for early and accurate detection of diseases i...
